If you or a loved one took Actemra and suffered from heart failure, heart attack, stroke, pancreatitis, interstitial lung disease, gastrointestinal perforation or death, then you may be able to receive financial compensation. Investigations are underway to determine the extent of the damages incurred by innocent patients after taking this drug.
Actemra was put on the market in 2010 and since then, countless patients have suffered needlessly due to complications linked to taking Actemra. Patients (both past and present) were never warned of the potential risks and were not given the opportunity to make a fully informed decision for their situation. Roche – Genentech knows that their drug puts patients at risk, and yet they still have failed to update their warning label when every other drug in its class has.
Roche – Genentech earned $1.7 Billion in sales from Actemra in 2016.
The statute of limitations and deadlines vary by state, so it is crucial to contact Periscope Group today. We want to be certain that you get the proper representation you need if you qualify to make a claim against Roche – Genentech.